Excerpts

Patients with ECOG PS 0 and EQD2 of ≥ 80 GyE 10 showed a trend toward higher PFS rates than those with ECOG PS 1–2 and EQD2 of < 80 GyE 10 with no statistical significance ( p > 0.05 each) ( Table 2 ) ( Figure S3B ).

In the IMspire150 study, triple therapy showed a significantly better PFS in patients with elevated LDH as well as a numerical trend towards better outcomes in patients with a high tumor mutational burden [ 30 ].

Although the prevalence of ESCC is always high, recent years have witnessed an increasing trend of EAC in the United States of America (USA) and other Western countries [ 6 , 7 ].

A larger difference was apparent after 96 h, when the numbers in the unsorted sample rose to about 17.8%, whereas the numbers in the CD34 − OV-6 − sample only rose to 10.5% on average. 3.3.

Kaplan–Meier curves showed a positive trend for tumor size < 5 cm and PFS (0.068).

As a matter of fact, a significant and almost significant higher number of NSC medium-grown and 1-EBIO-treated cells exhibited a large inward conductance and a high TRAM-34-sensitive conductance fraction, respectively, than 1-EBIO-treated DMEM medium cultivated cells.

In 2021, a decreasing trend of deaths and a better cancer survivorship were both observed and, more in general, between 2015 and 2021 mortality rates for all cancers reached a 10% and 8% decrease, respectively, among men and women.

Secondary Outcomes Time to onset of WHO severe mucositis was not significantly different between the two arms (log-rank test, p = 0.2429; Figure 2 A), but a positive trend was observed after SAMITAL treatment.

In the case of pancreatic tumors, new and higher denaturation temperatures appeared, and the enthalpy changed and as an indicator of the overall thermal stability of the whole system, showed a decreasing trend, particularly in inoperable cases.

In fact, almost any type of cancer tissue shows a highly significant reduction regarding hmC, but there is only a mild loss of mC [ 148 ].

Among the clinically high-risk sub-population, there were 14 events out of 42 genetically high-risk subjects defined by the 23-gene classifier, while only 2 events were observed during the 5-year follow up period from 137 genetically low-risk subjects predicted by the signature, resulting in a highly significant p -value of 0.0001 ( Figure 5 ).

Finally, all the effects of the included outcome predictors emerging from our prediction model were all statistically highly significant in the patients treated with ICIs.

A PCA plot of the 460 DEGs showed a trend of cluster separation between the responders and non-responders ( Figure 2 A).

Similarly, in Italy, the age-adjusted mortality was 0.031/100,000, with a significant trend of increase between 1995–2006 and a slight north–south gradient [ 65 ]. 4.3.

Thus, repeated intravenous administration of each nanotoxin in the SC EC model showed a highly significant antineoplastic effect, also mediated by apoptosis with DNA condensation and Caspase-3 and PARP cleavage.

The combination treatment also had the maximum percentage of tumor growth inhibition (TGI) at 82% compared to the control (0%), SAM (58%), and anti-PD-1 antibody (66%), although the TGI difference between the combination treatment and anti-PD-1 antibody alone was barely significant ( Figure 3 B).

p < 0.05 and <0.01 were considered statistically significant and highly significant, respectively.

There were borderline significant changes in CXCL9, TIM-3, IDO-1 and IFN-G expression and a trend toward upregulation of these genes was noted which was however, not statistically significant.

However, the patients with higher levels of CCAT2 showed a trend of worse disease-free survival and worse overall survival in TNBC patients ( Supplemental Figure S1A,B ), which is consistent with our previous report about the upregulation of CCAT2 in TNBC [ 25 ]. 3.2.

In line with StringDB findings, the results confirm a highly significant role for immune-related functions ( Figure 1 c)—with “lymphocyte activation” (GO:0046649), “adaptive immune response” (GO:0002250), and “B cell activation” (GO:0042113) being top predicted pathways ( p < 10 −20 ).

In univariate analyses of overall survival according to the treatment factors, 90 min HIPEC (HR 0.541, 95%-CI 0.300–0.978; p = 0.042) and treatment with cisplatin only (as opposed to cisplatin and doxorubicin, which yielded an HR of 2.269 95%-CI 1.230–4.186; p = 0.009) appeared to be significantly superior in terms of overall survival, whereas only a small trend was observed for CCR with a benefit of CC0 resected patients ( Figure 4 , Table 4 ).

Although quantification of caspase-3 positive cells in primary tumors failed statistical significance, there was a clear trend of increased apoptosis in the raloxifene/paclitaxel group.

Combining FN1 and COL3A1 with a logistic regression approach, the model was significantly associated with the tumor regression grade and pathological nodal stage and a statistical trend towards pCR [ 60 ].

Predictors of Ibrutinib Treatment for ≥5 Years In multivariate analysis, several baseline characteristics showed a trend toward continuation of ibrutinib treatment for ≥5 years (age ≤ 73 years, female sex, creatinine clearance ≥60 mL/min, TP53 mutated, del(11q), CLL histology, absence of bulky disease [<5 cm], β-2 microglobulin >3.5 mg/L, Rai stage III/IV, absence of cytopenia, and lactate dehydrogenase ≤250 U/L), but none reached statistical significance ( Figure 1 ). 3.3.

However, three consecutive island/promoter CpGs (cg26235537, cg10026577, cg02306970) were near significance after correction for the FDR and could constitute a VMR (variably methylated region) of positive correlation (Spearman’s rho = 0.5).